U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) insider Eric Joseph Williams sold 2,000 shares of U.S. Physical Therapy stock in a transaction on Friday, November 8th. The shares were sold at an average price of $95.84, for a total value of $191,680.00. Following the sale, the insider now directly owns 14,814 shares of the company’s stock, valued at approximately $1,419,773.76. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
U.S. Physical Therapy Trading Down 0.2 %
USPH opened at $91.87 on Thursday. The firm has a market cap of $1.39 billion, a price-to-earnings ratio of 97.73, a PEG ratio of 4.16 and a beta of 1.38. The company has a current ratio of 1.78, a quick ratio of 1.88 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 12 month low of $76.18 and a 12 month high of $113.63. The stock has a fifty day moving average price of $84.02 and a 200-day moving average price of $91.26.
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last announced its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.82 by ($0.09). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business had revenue of $167.19 million for the quarter, compared to analysts’ expectations of $163.34 million. During the same quarter last year, the firm earned $0.76 earnings per share. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. As a group, equities research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
Analysts Set New Price Targets
USPH has been the subject of a number of research analyst reports. Bank of America reaffirmed a “neutral” rating and set a $90.00 target price (down from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. Finally, Barrington Research reissued an “outperform” rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a research report on Thursday, November 7th.
Get Our Latest Analysis on USPH
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in USPH. BNP Paribas Financial Markets grew its stake in U.S. Physical Therapy by 6.8% during the 1st quarter. BNP Paribas Financial Markets now owns 7,837 shares of the company’s stock worth $885,000 after buying an additional 502 shares during the last quarter. Texas Permanent School Fund Corp grew its stake in U.S. Physical Therapy by 1.3% during the 1st quarter. Texas Permanent School Fund Corp now owns 13,116 shares of the company’s stock worth $1,480,000 after buying an additional 170 shares during the last quarter. Envestnet Portfolio Solutions Inc. purchased a new position in U.S. Physical Therapy during the 1st quarter worth $391,000. SG Americas Securities LLC purchased a new stake in U.S. Physical Therapy during the 1st quarter valued at about $485,000. Finally, Illinois Municipal Retirement Fund grew its stake in U.S. Physical Therapy by 2.7% during the 1st quarter. Illinois Municipal Retirement Fund now owns 8,683 shares of the company’s stock valued at $980,000 after purchasing an additional 230 shares during the last quarter.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Recommended Stories
- Five stocks we like better than U.S. Physical Therapy
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Rocket Lab is the Right Stock for the Right Time
- 3 REITs to Buy and Hold for the Long Term
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Airline Stocks – Top Airline Stocks to Buy Now
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.